US · VANI
Vivani Medical, Inc.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Alameda, CA 94608
- Website
- vivani.com
Price · as of 2024-12-31
$1.36
Market cap 72.67M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | — | — |
| Intrinsic Value(DCF) | — | — |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | $0.00 | $0.00 | |||
| 2014 | $342.72 | $148.36 | $27,079.59 | $0.00 | $0.00 |
| 2015 | $124.80 | $88.66 | $90,485.57 | $0.00 | $0.00 |
| 2016 | $34.56 | $22.88 | $0.00 | $0.00 | $268.74 |
| 2017 | $44.40 | $44.24 | $15.45 | $0.00 | $0.00 |
| 2018 | $18.48 | $18.20 | $0.00 | $0.00 | $19.14 |
| 2019 | $11.94 | $29.17 | $0.00 | $0.00 | $87.47 |
| 2020 | $45.60 | $70.49 | |||
| 2021 | $3.75 | ||||
| 2022 | $1.07 | ||||
| 2023 | $2.05 | ||||
| 2024 | $1.08 |
AI valuation
Our deep-learning model estimates Vivani Medical, Inc.'s (VANI) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- —
- Current price
- $1.36
- AI upside
- —
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
—
— upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| VANI | Vivani Medical, Inc. | $1.36 | 72.67M | — | — | — | — | -2.53 | 3.37 | — | -2.49 | — | 3.37 | 0.00% | — | — | -122.42% | -125.35% | -53.77% | 1.10 | — | 3.41 | 3.11 | -0.04 | -1400.00% | — | -1319.00% | -35.94% | -3.47 | -108.41% | 0.00% | 0.00% | 0.00% | -2.45 | -2.83 | — | -4.16 |
| CRDL | Cardiol Therapeutics Inc. | $1.02 | 113.91M | — | — | — | — | -3.18 | 4.71 | — | -2.15 | -19.96 | 4.71 | 0.00% | — | — | -138.47% | 660.06% | -106.99% | 0.01 | — | 4.52 | 4.41 | 0.76 | 1591.00% | — | -64.00% | -21.53% | -3.58 | 411.05% | 0.00% | 0.00% | 0.00% | -2.14 | -3.43 | — | -1.32 |
| EDAP | Edap Tms S.a. | $4.37 | 163.4M | +598% | -76% | — | — | -4.26 | 1.98 | 1.26 | -4.08 | — | 2.16 | 41.42% | -32.03% | -29.66% | -38.88% | -87.65% | -21.42% | 0.34 | -87.01 | 1.85 | 1.33 | 1.00 | -1053.00% | 611.00% | -679.00% | -21.85% | -0.36 | -75.49% | 0.00% | 0.00% | 0.00% | -3.17 | -3.68 | 1.01 | 0.14 |
| FONR | FONAR Corporation | $18.60 | 114.82M | +450% | -66% | +79% | -33% | 9.23 | 0.57 | 0.94 | 4.97 | — | 0.60 | 81.67% | 11.12% | 7.99% | 6.30% | 5.87% | 4.95% | 0.23 | 452.88 | 8.45 | 8.14 | -1.07 | -1961.00% | 143.00% | -4388.00% | 7.56% | 0.66 | 4.86% | 0.00% | 0.00% | 4.62% | 6.98 | 10.88 | 0.78 | 2.37 |
| HYPR | Hyperfine, Inc. | $1.07 | 81.53M | +2,340% | -64% | — | — | -1.74 | 1.45 | 5.51 | -0.80 | — | 1.45 | 45.70% | -335.33% | -315.90% | -61.03% | -410.39% | -53.19% | 0.01 | — | 6.15 | 5.26 | 0.89 | -968.00% | 1684.00% | -813.00% | -55.17% | -4.44 | -371.71% | 0.00% | 0.00% | 0.00% | -0.78 | -0.86 | 2.61 | -3.97 |
| IMA | ImageneBio Inc | $6.72 | 75.14M | +440% | +18% | — | +475% | -16.94 | 6.62 | 238.26 | -20.21 | — | 6.62 | 100.00% | -1057.14% | -1044.80% | -33.30% | -524.86% | -29.52% | 0.06 | — | 11.80 | 11.54 | 0.90 | -3742.00% | -6179.00% | -4261.00% | -5.52% | -4.27 | -652.59% | 0.00% | 0.00% | 0.00% | -19.38 | -15.59 | 204.87 | 28.99 |
| MBOT | Microbot Medical Inc. | $2.41 | 109.82M | — | — | — | — | -1.98 | 6.43 | — | -1.53 | — | 6.43 | 0.00% | — | — | -284.97% | 667.72% | -159.40% | 0.03 | — | 2.37 | 2.35 | 0.26 | -3048.00% | — | 334.00% | -39.02% | -3.59 | 508.44% | 0.00% | 0.00% | 3.38% | -1.49 | -1.96 | — | -21.36 |
| NSPR | InspireMD, Inc. | $1.78 | 75.42M | +1,242% | -35% | — | — | -3.72 | 3.30 | 16.99 | -2.61 | — | 3.30 | 21.49% | -478.00% | -456.63% | -84.68% | -1143.45% | -67.77% | 0.06 | — | 5.28 | 4.80 | 0.50 | -732.00% | 1296.00% | 3887.00% | -19.54% | -2.85 | -794.20% | 0.00% | 0.00% | 7.17% | -2.59 | -3.73 | 12.38 | -2.29 |
| ORMP | Oramed Pharmaceuticals In… | $3.42 | 136.08M | +1,195% | — | — | — | -5.13 | 0.67 | — | 2.94 | — | 0.67 | 0.00% | — | — | -12.29% | -43.99% | -10.14% | 0.00 | -14.98 | 25.19 | 24.97 | 3.63 | -43571.00% | -10000.00% | -2009.00% | -8.62% | -1.48 | -29.02% | 0.00% | 0.00% | 101.31% | 3.42 | 5.19 | — | 5.11 |
| QIPT | Quipt Home Medical Corp. | $3.63 | 161.41M | +679% | +41,027% | -84% | — | -9.83 | 0.75 | 0.31 | 5.02 | -17.48 | 183.07 | 70.09% | -1.56% | -3.13% | -8.67% | -2.44% | -3.34% | 0.85 | -0.79 | 1.46 | 0.64 | 2.52 | 5625.00% | 3883.00% | 108.00% | 24.09% | 0.50 | 11.61% | 0.00% | 0.00% | 0.12% | -39.68 | 8.33 | 0.62 | 0.40 |
| RCEL | AVITA Medical, Inc. | $5.03 | 124.96M | +486% | -58% | — | — | -3.02 | -8.82 | 2.05 | -3.30 | — | -6.59 | 82.13% | -58.56% | -67.85% | 799.72% | 463.33% | -71.40% | -0.13 | -8.38 | 0.57 | 0.44 | 0.20 | -2720.00% | 1145.00% | -4647.00% | -21.25% | -0.50 | 344.68% | 0.00% | 0.00% | 27.27% | -3.12 | -4.19 | 1.83 | -10.70 |
About Vivani Medical, Inc.
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
- CEO
- Adam Mendelsohn
- Employees
- 37
- Beta
- 3.34
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $1.36) − 1 = — (DCF, example).